A telephone survey conducted in 1997 ascertained opinions on the currently available glucagon emergency kits among patients with T1D, 67% of whom stated that they would prefer IN-administered glucagon if and when available, and 82% of whom believed that family members, teachers and colleagues would prefer to administer emergency therapy via IN in cases of severe hypoglycemia. The gene discussed is GCG; the disease is type 1 diabetes mellitus.